Fidelity Investments’s AbbVie ABBV Stock Holding History

Fidelity Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.9B	Sell	21,001,617 -2,634,965	-11%	-$489M	0.22%	60
2025 Q1	$4.95B	Buy	23,636,582 +5,539,207	+31%	+$1.16B	0.32%	37
2024 Q4	$3.22B	Buy	18,097,375 +4,466,971	+33%	+$794M	0.19%	73
2024 Q3	$2.69B	Buy	13,630,404 +511,470	+4%	+$101M	0.16%	95
2024 Q2	$2.25B	Buy	13,118,934 +630,537	+5%	+$108M	0.14%	111
2024 Q1	$2.27B	Buy	12,488,397 +1,397,770	+13%	+$255M	0.15%	101
2023 Q4	$1.72B	Sell	11,090,627 -180,845	-2%	-$28M	0.13%	128
2023 Q3	$1.68B	Buy	11,271,472 +371,842	+3%	+$55.4M	0.15%	121
2023 Q2	$1.47B	Sell	10,899,630 -1,985,856	-15%	-$268M	0.12%	137
2023 Q1	$2.05B	Sell	12,885,486 -1,478,010	-10%	-$236M	0.19%	98
2022 Q4	$2.32B	Sell	14,363,496 -655,720	-4%	-$106M	0.23%	78
2022 Q3	$2.02B	Sell	15,019,216 -2,392,966	-14%	-$321M	0.21%	80
2022 Q2	$2.67B	Sell	17,412,182 -1,194,012	-6%	-$183M	0.27%	60
2022 Q1	$3.02B	Buy	18,606,194 +1,542,954	+9%	+$250M	0.24%	57
2021 Q4	$2.31B	Sell	17,063,240 -4,553,434	-21%	-$617M	0.17%	94
2021 Q3	$2.33B	Sell	21,616,674 -13,840,304	-39%	-$1.49B	0.18%	92
2021 Q2	$3.99B	Sell	35,456,978 -1,206,825	-3%	-$136M	0.31%	48
2021 Q1	$3.97B	Buy	36,663,803 +7,609,661	+26%	+$824M	0.34%	41
2020 Q4	$3.11B	Sell	29,054,142 -1,203,037	-4%	-$129M	0.28%	54
2020 Q3	$2.65B	Sell	30,257,179 -1,112,935	-4%	-$97.5M	0.27%	54
2020 Q2	$3.08B	Sell	31,370,114 -3,636,195	-10%	-$357M	0.34%	43
2020 Q1	$2.67B	Sell	35,006,309 -5,232,576	-13%	-$399M	0.37%	42
2019 Q4	$3.56B	Buy	40,238,885 +2,928,045	+8%	+$259M	0.39%	42
2019 Q3	$2.83B	Buy	37,310,840 +10,566,142	+40%	+$800M	0.34%	48
2019 Q2	$1.94B	Buy	26,744,698 +13,544,557	+103%	+$985M	0.23%	78
2019 Q1	$1.06B	Buy	13,200,141 +4,765,946	+57%	+$384M	0.13%	146
2018 Q4	$778M	Sell	8,434,195 -273,259	-3%	-$25.2M	0.11%	173
2018 Q3	$824M	Buy	8,707,454 +1,574,495	+22%	+$149M	0.09%	192
2018 Q2	$661M	Sell	7,132,959 -11,268,487	-61%	-$1.04B	0.08%	249
2018 Q1	$1.74B	Buy	18,401,446 +3,496,715	+23%	+$331M	0.21%	101
2017 Q4	$1.44B	Buy	14,904,731 +6,469,978	+77%	+$626M	0.17%	119
2017 Q3	$750M	Buy	8,434,753 +1,938,588	+30%	+$172M	0.09%	229
2017 Q2	$471M	Sell	6,496,165 -395,242	-6%	-$28.7M	0.06%	325
2017 Q1	$449M	Buy	6,891,407 +745,555	+12%	+$48.6M	0.06%	356
2016 Q4	$385M	Sell	6,145,852 -5,123,067	-45%	-$321M	0.05%	402
2016 Q3	$706M	Sell	11,268,919 -3,342,032	-23%	-$210M	0.09%	224
2016 Q2	$896M	Sell	14,610,951 -11,464,820	-44%	-$703M	0.12%	174
2016 Q1	$1.49B	Sell	26,075,771 -18,081,533	-41%	-$1.03B	0.21%	93
2015 Q4	$2.62B	Buy	44,157,304 +4,303,452	+11%	+$255M	0.35%	47
2015 Q3	$2.17B	Buy	39,853,852 +8,356,232	+27%	+$455M	0.31%	57
2015 Q2	$2.12B	Buy	31,497,620 +10,103,184	+47%	+$679M	0.27%	65
2015 Q1	$1.25B	Sell	21,394,436 -12,676,377	-37%	-$742M	0.16%	143
2014 Q4	$2.23B	Sell	34,070,813 -47,266,208	-58%	-$3.09B	0.29%	65
2014 Q3	$4.7B	Buy	81,337,021 +24,251,445	+42%	+$1.4B	0.64%	18
2014 Q2	$3.22B	Sell	57,085,576 -12,123,971	-18%	-$684M	0.43%	39
2014 Q1	$3.56B	Sell	69,209,547 -3,935,295	-5%	-$202M	0.49%	34
2013 Q4	$3.86B	Buy	73,144,842 +13,164,507	+22%	+$695M	0.55%	24
2013 Q3	$2.68B	Buy	59,980,335 +1,445,261	+2%	+$64.6M	0.41%	44
2013 Q2	$2.42B	Buy	+58,535,074	New	+$2.42B	0.4%	45